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by Elsevier B.V. This is an open accesAbstract Background and objectives: Helicobacter pylori (H. pylori) infection has been
assumed to have roles in various extra-digestive diseases. The current study was designed to
evaluate the incidence of H. pylori infection in patients with cyclic vomiting syndrome and
its possible role in the etiology of this disease.
Design and setting: In this case-control study, 120 cases with diagnoses of cyclic vomiting or
abdominal migraine who were registered at the Gastroenterology Clinic at Shiraz University
of Medical Sciences from 2010 to 2013 were enrolled.
Materials and methods: Primarily information regarding the patients’ diseases were collected
with a data gathering sheet, and fresh morning stool samples were collected from the patients
and examined for H. pylori stool antigen with the H. pylori Ag EIA test kit. The results were
compared with those of healthy children from the control group.
Results: A total of 120 patients with cyclic vomiting (47.5%) and abdominal migraine (52.5%)
with a mean age of 7.1  3.4 (range 2e16 years) and a male-to-female ratio of 1.6 were
included. The HPs Ag tests were positive in only 7 (5.8%) patients in our case group, and the
HPs Ag tests were positive in 13 (13%) of the children in the control group; this difference
was statistically insignificant.
Conclusion: Our study did not support H. pylori infection as an etiological factor in CV or AM.
Copyright ª 2015, King Faisal Specialist Hospital & Research Centre (General Organization),
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Within several years of its discovery in approximately 1982,
the association of Helicobacter pylori (H. pylori) infection
with antral gastritis was completely accepted [1]. However,
in recent years, in addition to its gastrointestinal functions,
the roles of H. pylori infection have been assumed to
extend to various extra-digestive diseases [2].
The pathogeneses of these extra-intestinal manifesta-
tions seem to be related to the chronic nature of the
infection and the persistent inflammation it causes. It has
been proposed that this chronic inflammation can have
direct (i.e., the effects of the infectious agent on the
vascular wall) and indirect (i.e., the production of inflam-
matory mediators) effects, which likely explain the asso-
ciation of these extra digestive diseases with H. pylori
infection [3].
Different studies have revealed the involvement of this
infection within vascular [4e7], autoimmune [8,9], and skin
diseases [10]. Lately, many studies have implicated the
relationship between H. pylori infection and migraine
headaches in both children and adults [11e14]. The basis of
these studies is related to the fact that migraine headaches
seem to have a vascular pathogenesis [15]; moreover, pre-
vious investigations have revealed the relation of H. pylori
infection with diseases of vascular origin, such as athero-
sclerosis and the Raynaud phenomena [16,17]. As previously
explained, the probable pathogenic role of chronic H. pylori
infection in these cases is based on the relationship between
the host immune response against the bacterium and the
chronic release of vasoactive substances [13].
The link between cyclic vomiting (CV) and migraine
headaches was first expressed in 1904 [18]. Due to simi-
larity of the stereotypical clinical presentations, the pro-
gression of CV to migraine headaches, and the frequent
occurrence of CV in children with family histories of
migraine, later in 1933, Wyllie and Schlesinger described a
term called childhood periodic syndrome that included
abdominal migraine (AM), cyclic vomiting syndrome, andTable 1 Diagnostic criteria for abdominal migraine and Cyclic
Abdominal migraine
A- At least 5 attacks fulfilling criteria B-D
B- Attacks of abdominal pain lasting 1e72 h
(untreated or successfully treated)
C- Abdominal pain with all of the following
characteristics:
1. Midline location, periumbilical or poorly localized
2. A dull or only sore quality
3. Moderate or severe intensity
D- During abdominal pain at least 2 of the
following occur:
1. Anorexia
2. Nausea
3. Vomiting
4. Pallor
E- Not attributable to any other disorder
a IHC_ Classification-ICHD_I.benign paroxysmal vertigo that persists into adult life as
migraine attacks [19]. In the recent years, this syndrome
has been accepted as a migraine variant in children [20].
The cause of CV is still unknown; however, due to the
resemblance of their clinical presentations, it has been
speculated that migraine headaches and CV share similar
mechanisms [21]. Other hypotheses that have been
described for the pathogenesis of these diseases include
autonomic instability, disturbances in the hypothalamic-
pituitary-adrenal axis, mitochondrial disorders, and ab-
normalities in ion channels [22].
Based on these facts, the current study was designed to
evaluate the incidence of H. pylori infection in patients
with CV as a possible etiologic factor in the pathogenesis of
the disease that has not previously been proposed
elsewhere.
2. Materials and methods
One hundred twenty cases with diagnoses of CV or AM ac-
cording to the IHC_ Classification ICHD_II (Table 1) [23] who
were registered at the Gastroenterology Clinic at Shiraz
University of Medical Sciences from 2010 to 2013 were
enrolled in this study. Moreover, a control group consisting of
healthy children who were referred to the out-patient clinic
affiliated with the Shiraz University of Medical Sciences for
routine health care visits was considered. These children
were matched to the case group in terms of age and sex.
All patients and their parents were informed of the aims
of the study, and written consent was attained. This study
was approved by the ethical committee of our institution.
Prophylactic treatment with propranolol (1 mg/kg/day)
had been initiated for all of the patients following the di-
agnoses of CV or AM, and this treatment had been gradually
tapered in the patients group (50.8%) who had been
symptom free for at least 6 months on prophylactic
medication.
Primarily information regarding the patients’ diseases
was collected on data-gathering sheets and includedvomiting.a
Cyclic vomiting
A- At least 5 attacks fulfilling criteria B and C
B- Episodic attacks that are stereotypical in the individual
patient and include intense nausea and vomiting lasting
from 1 h to 5 days
C- Vomiting during attacks occurs at least 4 times/hour
for at least 1 h
D- Symptom-free between attacks
E- Not attributable to any other disorder
Table 2 Comparison of the HPs Ag results and the char-
acteristics of the patients’ diseases.
Disease characteristic HPs Ag results
HPS AGaþ HPS Ag
Age (mean year SD) 7.2  3.8 7.1  3.4
Male to female ratio 2.5 1.6
Duration of illness
(mean year  SD)
3.3  2.7 1.3  1.2
Frequency of attacks per year
(mean episodes  SD)
2.7  2.7 1.4  1.3
Duration of attacks
(mean days  SD)
2.4  1.9 1.4  1.5
Positive family history
of migraine %
57.1 52.2
Consumption of Propranolol
at the present time %
14.3 51.3
a HPS Ag: helicobacter pylori stool antigen.
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frequency of attacks per year, the duration of each attack,
the associated symptoms, the drugs received, and positive
family histories of migraine headaches.
Furthermore, fresh morning stool samples were
collected from each child for the evaluation of the H. pylori
antigen. At the time of sampling, the patients were on no
medications, such as antibiotics or proton pump inhibitors.
The patients were educated regarding how to avoid
contaminating the stool samples with urine or water as such
contamination could lead to false laboratory results. The
collected samples were stored at 2e8 C and immediately
delivered to the laboratory within 24 h of collection. H.
pylori stool antigens were examined using the H. pylori Ag
EIA test kit.
Cases in which H. pylori infections had previously been
diagnosed and that had received proton pump inhibitors
(PPI) or regimes for the eradication of H. pylori infection
were excluded from our study.
The data gathered from each patient were recorded,
coded, and entered into the computer using the SPSS pro-
gram version 16.0 (SPSS software version 16.0 manufac-
tured by IBM, United states of America). The statistical
analyses were performed using chi-square or Fisher’s exact
tests for evaluation and comparison.
3. Results
A total of 120 patients with CV (47.5%) and AM (52.5%) with
a mean age of 7.1  3.4 (range 2e16 years) and a male-to-
female ratio of 1.6 were included. Additionally 100 healthy
children with a mean age of 6.9  3.1 and a male-to-female
ratio of 1.4 were included as the control group. None of the
children has previously been diagnosed with H. pylori
infection or had received drugs such as PPIs or bismuth
salts.
The HPs Ag tests were positive in only 7 (5.8%) of pa-
tients (3 with CV and 4 with AM) in our case group. The HPs
Ag tests were positive in 13 (13%) of the children of the
control group. This difference between the case and con-
trol groups was not significant. However, there was a sig-
nificant positive relationship between HPs Ag positivity and
age in our control group (P < .05).
There were significant relationships of HPS Ag positivity
in the case group with the duration of each attack and the
consumption of propranolol. The HPs Ag-positive group
exhibited greater attack durations (2.4  1.9 days)
compared to the HPs Ag-negative group (1.4  1.5;
P Z .02); moreover, the HPs Ag-positive group exhibited
lower propranolol consumption levels than the HPs Ag-
negative group (14.3% vs. 51.3%; P Z .05). Regarding the
associations between the HPs Ag results and the other as-
pects of the patients’ illnesses, there were no significant
relationships (PV > 0.05; Table 2).
4. Discussion
H. pylori infection is considered to be the most common
chronic infection in the world [24]. This infection is typi-
cally acquired in early childhood and persists into adult life
[25]. In recent years, there seems to have been a decline inthe prevalence of H. pylori in Western countries; results
have shown that the incidence is less than 10% in North
America and Europe; however, the infection is highly
prevalent in many developing countries [26,27]. For
example, in a study from the Czech Republic that was
performed by Sykora et al, in 2009 a prevalence of H. pylori
infections in healthy children of 7% was reported based on
the stool antigen method [28]; moreover, a from South
Africa that used the same screening method for the
detection of the infection revealed a prevalence of 87% in
healthy children [29]. In the current study, we have re-
ported a prevalence of H. pylori infection of 13% in healthy
Iranian children at our geographical region of Southern Iran.
This contrasts with a report from years ago by Malekzade
et al that reported a much greater prevalence (82%) of
infection in the same area [30].
In 1996, Crabtree proposed that the direct and indirect
release of vasoactive substances is the pathogenic mecha-
nism associated with H. pylori infection and functional
vascular disorders, such as atherosclerosis and the Raynaud
phenomenon [31]. Considering that migraine headache is
believed to have a functional vascular pathogenesis, many
recent studies have implicated the role of H. pylori infec-
tion in this disease [6,14,31e33]. The results of these
studies showed that the intensity, duration, and frequency
of attacks of migraine were significantly reduced in pa-
tients in whom H. pylori had been eradicated.
With the knowledge that migraine headaches and
childhood periodic syndromes seem to share pathogenic
resemblances, in the present study, we investigated the
role of H. pylori infection in the pathogeneses of CV and AM
for the first time. H. pylori colonization was found in only 7
cases (5.8%) of our patients who were suffering from CV or
AM, and no influences of age or sex were found. H. pylori
infection was significantly higher among patients with
longer disease durations (in days) but not among those with
more frequent of attacks.
Worldwide, many studies have implied that H. pylori
infection is transmitted within the family and primarily
from the parents to the child [34e36]. Here, we did not
observe any significant relationship between a positive
22 A. Erjaee et al.family history of migraine headache in the first-degree
relatives of our patients and the incidence of H. pylori
infection.
Despite the controversies regarding treatment (i.e.,
abortive, supportive, and prophylactic) and the durations
of therapy for CV and AM, the majority of studies have
recommended antimigraine drugs such as pizotifen, pro-
pranolol and cyproheptadine as effective prophylactic re-
gimes for these conditions [37e39]. In 2007 our
gastroenterology center at Shiraz University of Medical
Sciences reported an experience on 181 CV cases in which
propranolol was recommended as the first drug of choice
for prophylaxis in children with CV. Moreover, in this study,
propranolol was discontinued in approximately half of the
patients who had been asymptomatic for at least 5 months,
and only a few recurrences were observed at a one-year
follow up [39].
Considering the previous experiences of our center, we
began propranolol for all of our patients following the di-
agnoses of CV or AM and gradually discontinued this medi-
cation in those without any symptoms after at least six
months of therapy.
In this study, we showed a lower incidence of H. pylori
infection in the patients who were on prophylactic treat-
ment with propranolol. At the present time, we have no
specific explanation for this finding; furthermore, whether
propranolol might have caused false negative results in the
H. pylori stool antigen tests remains a question that will
require further investigation.
5. Conclusions
Our study did not support the H. pylori infection as an
etiological factor of either CV or AM. Furthermore, we re-
ported a significantly lower prevalence of H. pylori in the
healthy population of children in southern Iran, which
might have been due to the decrease in family sizes and the
improvement in living styles that have occurred in recent
years. Therefore, this low prevalence does not exclude the
role of H. pylori in these childhood periodic syndromes. The
question remains regarding the possibly that the cure of H.
pylori might lead to the relief of symptoms in our patients.
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